Could poop transplants save sepsis patients?
NCT ID NCT07670299
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether fecal microbiota transplantation (FMT) can help ICU patients with sepsis. Sepsis is a life-threatening infection that can cause organ failure. The trial will give 60 adults either standard care or standard care plus FMT through a tube into the gut for three days. The main goal is to see if FMT reduces deaths within 90 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
fecal microbiota transplantation (FMT)
What this could lead to
If it works, this could point toward a new treatment to lower death rates in ICU sepsis patients by restoring gut health.
What could go wrong
This is a small, early-stage trial with only 60 patients at one hospital. The treatment may not work or could cause side effects like fever or gut issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••